Delta Virus Infection and Severe Hepatitis

An Epidemic in the Yucpa Indians of Venezuela

  1. STEPHEN C. HADLER, M.D.;
  2. MARIA DE MONZON, M.D.;
  3. ANTONIO PONZETTO, M.D.;
  4. ELIAS ANZOLA, M.D.;
  5. DALIA RIVERO, M.D.;
  6. ALEJANDRO MONDOLFI, M.D.;
  7. ANA BRACHO, M.D.;
  8. DONALD P. FRANCIS, M.D., D.Sc.;
  9. MICHAEL A. GERBER, M.D.;
  10. SWAN THUNG, M.D.;
  11. JOHN GERIN, Ph.D.;
  12. JAMES E. MAYNARD, M.D., Ph.D.;
  13. HANS POPPER, M.D., Ph.D.; and
  14. ROBERT H. PURCELL, M.D.
  1. Phoenix, Arizona; Maracaibo and Caracas, Venezuela; Rockville and Bethesda, Maryland; and New York, New York

    Abstract

    Over a 3-year period, 149 Yucpa Indians in Venezuela developed hepatitis; 34 persons died and at least 22 developed chronic hepatitis. Children and young adults were primarily affected, especially males. Serologic testing showed that hepatitis B virus infection was highly endemic in this population, but also that 65% of patients had hepatitis B virus surface antigen (HBsAg) during or after illness. Most patients had evidence of delta-agent superinfection; 86% of HBsAg-positive patients had delta antibody, and delta antigen was found in specimens taken during autopsies on 7 of 9 patients. Serologic data suggested that most infections were due to delta superinfection of hepatitis B carriers, and that more than 60% of these infections progressed to chronic disease. Delta agent infection, and particularly delta superinfection of hepatitis B carriers, appears to be an ominous occurrence that may develop in populations among whom hepatitis B virus infection is endemic, and who have no other risk factor for delta infection.

    Article and Author Information

    • ▸From the Division of Hepatitis and Viral Enteritis, CID, Centers for Disease Control, Phoenix, Arizona; South General Hospital, Maracaibo, Venezuela; the Ministry of Health, Caracas, Venezuela; Division of Molecular Virology, Georgetown University, Rockville, Maryland; the National Institutes of Health, Bethesda, Maryland; and Mt. Sinai School of Medicine, New York, New York.

    • ▸Requests for reprints should be sent to Stephen C. Hadler, M.D.; Hepatitis Branch—Viral Diseases, Centers for Disease Control, 1600 Clifton Road, Building 6, Room 154; Atlanta, GA 30333.

    « Previous | Next Article »Table of Contents